Journal of Pharmaceutical Sciences p. 471 - 477 (1984)
Update date:2022-08-04
Topics:
Dimmock
Shyam
Logan
Smith
Cross
A number of analogues of 3-dimethylamino-2-dimethylaminomethyl-1-(4-methoxyphenyl)-1-propanone dihydrochloride (IIa) and related compounds which showed activity against P388 lymphocytic leukemia were prepared, and of the 16 analogues, three met the criterion for activity in this screen. The toxicity of IIa was examined in rats and either single dose of 25 mg/kg or nine daily doses of 12.5 mg/kg administered by the intraperitoneal route produced marked irritation and damage to the tissue with which it came into contact. Compound IIa did not show significant activity against eight other tumor systems.
View MoreJintan City Mego Chemical Co., Ltd
Contact:+86-0519-82814387
Address:23# Dengguan Town, Jintan, Jiangsu Province, China
Shanghai Potomer International Trade CO., LTD
Contact:+86-21-61397128
Address:Room 304,No.505 ,Caoyang Road.Shanghai,China
Contact:0086-22-23410962
Address:17-201, Ningfuli, Shuishanggongyuandong road,Nankai district, Tianjin, China
Contact:+44 (0)161 367 9441
Address:
Binzhou Holly Pharmaceutical Co.,Ltd.
Contact:74517
Address:No.15 Dapu Road,Huangpu District Shanghai,P.R.China
Doi:10.1021/jm060193m
(2006)Doi:10.1016/j.bmcl.2006.04.085
(2006)Doi:10.1002/hlca.201000463
(2011)Doi:10.1021/jacs.1c01951
(2021)Doi:10.1016/0040-4020(84)85098-X
(1984)Doi:10.1021/acs.joc.9b02453
(2019)